Sign Out
Ovidrel is indicated in the treatment of: Adult women undergoing superovulation prior to assisted reproductive technologies (ART) such as in vitro fertilization (IVF): Ovidrel is administered to trigger final follicular maturation and luteinisation after stimulation of follicular growth.
Anovulatory or oligo-ovulatory women: Ovidrel is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory patients after stimulation of follicular growth.
